Manchester University (UK) scientists have a developed a new method to monitor the
effect of anti-cancer drugs on very rare leukaemia stem cells. The
approach potentially allows doctors to screen patients and personalise
their treatment.
Showing posts with label chronic myeloid leukaemia. Show all posts
Showing posts with label chronic myeloid leukaemia. Show all posts
Saturday, February 28, 2015
Sunday, October 5, 2014
Glivec
- What is Glivec?
Glivec is a medicine that contains the active substance imatinib. It is available as capsules (50 and 100 mg) and tablets (100 and 400 mg).
Subscribe to:
Posts (Atom)